Jennifer Jarrett - Mar 16, 2022 Form 4 Insider Report for Arcus Biosciences, Inc. (RCUS)

Signature
/s/ Carolyn Tang, Attorney-in-Fact
Stock symbol
RCUS
Transactions as of
Mar 16, 2022
Transactions value $
-$304,090
Form type
4
Date filed
3/18/2022, 04:43 PM
Previous filing
Mar 11, 2022
Next filing
May 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCUS Common Stock Sale -$304K -9.62K -8.32% $31.62 106K Mar 16, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.